Jauquet M, Gagnepain P, La Porte E, Thiebaut A, Rochey A, Legros H
Ann Clin Transl Neurol. 2024; 11(11):2877-2890.
PMID: 39257037
PMC: 11572725.
DOI: 10.1002/acn3.52197.
Everts P, Lana J, Alexander R, Dallo I, Kon E, Ambach M
Int J Mol Sci. 2024; 25(14).
PMID: 39063156
PMC: 11277244.
DOI: 10.3390/ijms25147914.
Svensson T, Svensson A, Kitlinski M, Engstrom G, Nilsson J, Orho-Melander M
BMC Med. 2024; 22(1):173.
PMID: 38649900
PMC: 11035142.
DOI: 10.1186/s12916-024-03392-1.
Wolf A, Khimani F, Yoon B, Gerhart C, Endsley D, Ray A
Thromb Update. 2024; 8:100110.
PMID: 38620974
PMC: 9116969.
DOI: 10.1016/j.tru.2022.100110.
De Luca M, Crisci G, Armentaro G, Cicco S, Talerico G, Bobbio E
Life (Basel). 2024; 14(1).
PMID: 38255646
PMC: 10817572.
DOI: 10.3390/life14010030.
Coagulation Factors and Natural Anticoagulants as Surrogate Markers of Preeclampsia and Its Subtypes: A Case-Control Study in a Ghanaian Population.
Mintaah S, Anto E, Boadu W, Sackey B, Boateng L, Ansah E
Clin Appl Thromb Hemost. 2023; 29:10760296231204604.
PMID: 37787124
PMC: 10548802.
DOI: 10.1177/10760296231204604.
and Pro-Inflammatory Protein Biomarkers in Myocardial Infarction with and without Obstructive Coronary Artery Disease.
Warme J, Sundqvist M, Hjort M, Agewall S, Collste O, Ekenback C
Int J Mol Sci. 2023; 24(18).
PMID: 37762446
PMC: 10531769.
DOI: 10.3390/ijms241814143.
Plasma tissue-type plasminogen activator is associated with lipoprotein(a) and clinical outcomes in hospitalized patients with COVID-19.
Zhang Z, Dai W, Zhu W, Rodriguez M, Lund H, Xia Y
Res Pract Thromb Haemost. 2023; 7(6):102164.
PMID: 37680312
PMC: 10480648.
DOI: 10.1016/j.rpth.2023.102164.
Biofunctionalization of cardiovascular stents to induce endothelialization: Implications for in- stent thrombosis in diabetes.
Marei I, Ahmetaj-Shala B, Triggle C
Front Pharmacol. 2022; 13:982185.
PMID: 36299902
PMC: 9589287.
DOI: 10.3389/fphar.2022.982185.
Modulation of endothelium function by fatty acids.
Mallick R, Duttaroy A
Mol Cell Biochem. 2021; 477(1):15-38.
PMID: 34529222
PMC: 8755678.
DOI: 10.1007/s11010-021-04260-9.
Updates on Anticancer Therapy-Mediated Vascular Toxicity and New Horizons in Therapeutic Strategies.
Hsu P, Mammadova A, Benkirane-Jessel N, Desaubry L, Nebigil C
Front Cardiovasc Med. 2021; 8:694711.
PMID: 34386529
PMC: 8353082.
DOI: 10.3389/fcvm.2021.694711.
Role of Shear Stress and tPA Concentration in the Fibrinolytic Potential of Thrombi.
Whyte C, Mostefai H, Baeten K, Lucking A, Newby D, Booth N
Int J Mol Sci. 2021; 22(4).
PMID: 33672724
PMC: 7924342.
DOI: 10.3390/ijms22042115.
Targeting PAI-1 in Cardiovascular Disease: Structural Insights Into PAI-1 Functionality and Inhibition.
Sillen M, Declerck P
Front Cardiovasc Med. 2021; 7:622473.
PMID: 33415130
PMC: 7782431.
DOI: 10.3389/fcvm.2020.622473.
Overview of the Assessment of Endothelial Function in Humans.
Chia P, Teo A, Yeo T
Front Med (Lausanne). 2020; 7:542567.
PMID: 33117828
PMC: 7575777.
DOI: 10.3389/fmed.2020.542567.
Novel anti-thrombotic mechanisms mediated by Mas receptor as result of balanced activities between the kallikrein/kinin and the renin-angiotensin systems.
Fang C, Schmaier A
Pharmacol Res. 2020; 160:105096.
PMID: 32712319
PMC: 7378497.
DOI: 10.1016/j.phrs.2020.105096.
Antiviral anticoagulation.
Pryzdial E, Sutherland M, Lin B, Horwitz M
Res Pract Thromb Haemost. 2020; 4(5):774-788.
PMID: 32685886
PMC: 7354393.
DOI: 10.1002/rth2.12406.
Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence.
Sardu C, Gambardella J, Morelli M, Wang X, Marfella R, Santulli G
J Clin Med. 2020; 9(5).
PMID: 32403217
PMC: 7290769.
DOI: 10.3390/jcm9051417.
Urokinase Plasminogen Activator: A Potential Thrombolytic Agent for Ischaemic Stroke.
Kadir R, Bayraktutan U
Cell Mol Neurobiol. 2019; 40(3):347-355.
PMID: 31552559
PMC: 11448917.
DOI: 10.1007/s10571-019-00737-w.
Fibrinolysis and Inflammation in Venous Thrombus Resolution.
Mukhopadhyay S, Johnson T, Duru N, Buzza M, Pawar N, Sarkar R
Front Immunol. 2019; 10:1348.
PMID: 31258531
PMC: 6587539.
DOI: 10.3389/fimmu.2019.01348.
Alu DNA Polymorphism of Human Tissue Plasminogen Activator (tPA) Gene in Diabetic Jordanian Patients.
Yasin S, Alhawari H, Alassaf A, Khadra M, Al-Mazaydeh Z, Al-Emerieen A
Iran Biomed J. 2019; 23(6):423-8.
PMID: 31104419
PMC: 6800539.